These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4946007)

  • 1. Clinical note. Phase II study of 1-aminocyclopentanecarboxylic acid (NSC-1026) in patients with cancer.
    Aust JB; Andrews NC; Schroeder JM; Lawton RL
    Cancer Chemother Rep; 1970 Aug; 54(4):237-41. PubMed ID: 4946007
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy in prevention of the recurrence of resectable cancer.
    Bonadonna G; Tancini G; Rossi A; Gasparini M
    Annu Rev Med; 1978; 29():149-75. PubMed ID: 206184
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.
    Kovach JS; Moertel CG; Schutt AJ; Reitemeier RG; Hahn RG
    Cancer Chemother Rep; 1973; 57(3):357-9. PubMed ID: 4584486
    [No Abstract]   [Full Text] [Related]  

  • 4. 6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study.
    Fink DJ; Foye LV
    Cancer Chemother Rep; 1970 Feb; 54(1):31-4. PubMed ID: 4945996
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II studies of homoharringtonine in patients with advanced malignant melanoma; sarcoma; and head and neck, breast, and colorectal carcinomas.
    Ajani JA; Dimery I; Chawla SP; Pinnamaneni K; Benjamin RS; Legha SS; Krakoff IH
    Cancer Treat Rep; 1986 Mar; 70(3):375-9. PubMed ID: 3955548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further clinical studies of trimethylpurin-6-ylammonium chloride (NSC-51095) in malignant disease with special emphasis on cancer of urinary bladder.
    Phillips RW
    Cancer Chemother Rep; 1970 Jun; 54(3):181-5. PubMed ID: 4947750
    [No Abstract]   [Full Text] [Related]  

  • 7. Daunorubicin treatment of adult solid tumors.
    Weiss RB; Bruno S
    Cancer Treat Rep; 1981; 65 Suppl 4():25-8. PubMed ID: 7049378
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of antileukemic action and toxicity of 1-aminocyclopentanecarboxylic acid in mice by L-valine.
    Gregory FJ; Flint SF; Ruelius HW; Warren GH
    Cancer Res; 1969 Mar; 29(3):728-9. PubMed ID: 5773815
    [No Abstract]   [Full Text] [Related]  

  • 9. Cis-diamminedichloroplatinum (II). A new anticancer drug.
    Rozencweig M; von Hoff DD; Slavik M; Muggia FM
    Ann Intern Med; 1977 Jun; 86(6):803-12. PubMed ID: 326117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cis-diamminedichloroplatinum (NSC-119875): a phase I study.
    Higby DJ; Wallace HJ; Holland JF
    Cancer Chemother Rep; 1973; 57(4):459-63. PubMed ID: 4586953
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma.
    Marciniak TA; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(4):761-3. PubMed ID: 1100228
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of experimental pancreatitis using l-aminocyclopentanecarboxylic acid].
    Alvizouri M
    Gac Med Mex; 1970 Feb; 100(2):184-93. PubMed ID: 5441487
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of high-dose intermittent cycloleucine in colorectal malignancies.
    Dindogru A; Leichman LP; Cummings G; Baker LH
    Cancer Treat Rep; 1982 Jan; 66(1):203-4. PubMed ID: 7053260
    [No Abstract]   [Full Text] [Related]  

  • 14. [New perspectives for an adjuvant chemotherapy in solid tumors].
    Schmidt CG; Seeber S
    Dtsch Med Wochenschr; 1975 Nov; 100(45):2342-8. PubMed ID: 171129
    [No Abstract]   [Full Text] [Related]  

  • 15. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
    Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytostatic modifiers: current status and considerations for the future.
    Howell SB; Goel R
    Acta Chir Scand Suppl; 1988; 541():22-31. PubMed ID: 3291516
    [No Abstract]   [Full Text] [Related]  

  • 17. Single reversal trial of hydroxyurea (NSC-32065) in 91 patients with advanced cancer.
    Slack NM; Jones R
    Cancer Chemother Rep; 1970 Feb; 54(1):53-63. PubMed ID: 4945998
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical studies with nitrosoureas in various solid tumors.
    Slavik M
    Cancer Treat Rep; 1976 Jun; 60(6):795-800. PubMed ID: 986243
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase 2 study with Baker's Antifol in solid tumors.
    Rodriguez V; Richman SP; Benjamin RS; Burgess MA; Murphy WK; Valdivieso M; Banner RL; Gutterman JU; Bodey GP; Freireich EJ
    Cancer Res; 1977 Apr; 37(4):980-3. PubMed ID: 139205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitomycin (Mutamycin).
    Med Lett Drugs Ther; 1975 Jul; 17(15):62-3. PubMed ID: 50555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.